Nerium SkinCare is dedicated to “evidence-based” product development. Quite simply, the company believes that preclinical and clinical testing of its products is essential prior to the release of a given product to the public. Nerium SkinCare does not rely merely on published work by others, but provides for appropriately designed studies of its own to insure safety and efficacy.
When asked to describe the precautions and protocols that Nerium SkinCare uses to ensure it meets all safety standards, Dr. Robert Newman, scientific advisor to Nerium SkinCare, responded, “Both preclinical and clinical safety testing is performed on Nerium SkinCare product. Importantly, this is NOT done using animals. Rather, the research relies on in vitro cell culture, as well as actual human clinical studies. The clinical studies are carried out in volunteers, typically using small, defined areas of skin or other target tissue sites, which include additional safety precautions utilizing blood chemistry’s and CBC analysis for each participant. Once safety is assured, larger scale clinical testing and analysis is then done.”
The skincare market is filled with products that have little, if any, evidence-based research behind them. Often, what is saved in terms of research simply goes into marketing. Nerium SkinCare’s philosophy stands in stark contrast to that, as the company will not release any product without safety and evidence-based proof of product performance and efficacy.
The discovery of using Nerium oleander in a skincare capacity was truly accidental. Following this finding, scientific steps were taken to create a product harnessing the power of Nerium oleander. This process included the selection of appropriate product components (such as
aloe), development of innovative technology related to the extraction of Nerium oleander leaves, unique blending of the aloe-based oleander extract into a useful cream-based cosmetic product, safety testing, and preclinical and clinical testing to assure product efficacy and utility.
The skincare market is filled with products that have little, if any, evidence-based research behind them. Nerium SkinCare’s philosophy stands in stark contrast
Robert A. Newman, Ph.D. Chairman of the Scientific Advisory Board
Dr. Newman obtained his M.S. and Ph.D. degrees in Pharmacology and Toxicology from the University of Connecticut and then served in postdoctoral positions at the Medical School of the University of Georgia, as well as the Department of Biochemistry at the University of Vermont. He served as a faculty member at the University of Vermont Medical School for seven years and then spent a sabbatical year at Stanford University performing research on immune targeted therapy. He has spent the last 24 years at the University of Texas M. D. Anderson Cancer Center in Houston, Texas, where he served as the Founder and Co-Director of the Pharmaceutical Development Center. He has published over 300 articles dealing with the pharmacology, toxicology, and development of anticancer drugs. Dr. Newman remains actively involved in continuing research as Scientific Advisor to Phoenix Biotechnology, Inc.
©2012 NeriumTMInternational. All Rights Reserved. Revised 8/12